Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

Quotazioni in diretta

CGEM Cullinan Therapeutics Inc

12,18

-0,02 (-0,16%)

31 Dic 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The securities to be sold were and will be received upon the exercise of stock options over the next three months. The date of acquisition and payment were and will be the date of exercise/sale. The securities to be sold were acquired upon the vesting of restricted stock units during the period of 12/01/2018 through 6/17/2023.

Date of Notice

05/06/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

01/05/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Jennifer Michaelson

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Cullinan Therapeutics (NASDAQ:CGEM)
Storico
Da Dic 2024 a Gen 2025

Clicca qui per i Grafici di Cullinan Therapeutics

Grafico Azioni Cullinan Therapeutics (NASDAQ:CGEM)
Storico
Da Gen 2024 a Gen 2025

Clicca qui per i Grafici di Cullinan Therapeutics

Notizie Cullinan Therapeutics Inc - CGEM

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 20 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 20 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 20 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunedì 16 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Giovedì 14 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
Giovedì 14 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Venerdì 8 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 7 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Giovedì 7 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 7 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Giovedì 7 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
Martedì 5 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Più Cullinan Therapeutics Inc Articoli Notizie

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea